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Abstract
Background: To understand the causal basis of TNF associations with disease, it is necessary to
understand the haplotypic structure of this locus. We genotyped 12 single-nucleotide
polymorphisms (SNPs) distributed over 4.3 kilobases in 296 healthy, unrelated Gambian and
Malawian adults. We generated 592 high-quality haplotypes by integrating family- and population-
based reconstruction methods. 
Results:  We found 32 different haplotypes, of which 13 were shared between the two
populations. Both populations were haplotypically diverse (gene diversity = 0.80, Gambia; 0.85,
Malawi) and significantly differentiated (p < 10-5 by exact test). More than a quarter of marker
pairs showed evidence of intragenic recombination (29% Gambia; 27% Malawi). We applied two
new methods of analyzing haplotypic data: association efficiency analysis (AEA), which describes
the ability of each SNP to detect every other SNP in a case-control scenario; and the entropy
maximization method (EMM), which selects the subset of SNPs that most effectively dissects the
underlying haplotypic structure. AEA revealed that many SNPs in TNF are poor markers of each
other. The EMM showed that 8 of 12 SNPs (Gambia) and 7 of 12 SNPs (Malawi) are required to
describe 95% of the haplotypic diversity. 
Conclusions: The TNF locus in the Gambian and Malawi sample is haplotypically diverse and has
a rich history of intragenic recombination. As a consequence, a large proportion of TNF SNPs
must be typed to detect a disease-modifying SNP at this locus. The most informative subset of
SNPs to genotype differs between the two populations.
Published: 17 March 2003
Genome Biology 2003, 4:R24
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2003/4/4/R24
Received: 12 July 2002
Revised: 8 December 2002
Accepted: 24 January 2003
Background 
The  TNF locus (MIM *191160) has been associated with
susceptibility to a wide range of infectious and inflamma-
tory  diseases, including malaria, typhoid, leishmaniasis,
meningococcal sepsis, trachoma, asthma, multiple sclerosis,
and inflammatory bowel disease [1-11]. Thus far, these asso-
ciations have not been mapped in any detail, and as TNF
lies in the central part of the major histocompatibility
Open Access
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potentially be responsible. A strong candidate is TNF itself,
as it encodes the potent pro-inflammatory cytokine TNF,
and there is a significant body of clinical and experimental
data suggesting a causal role for it in the pathogenesis of
many of the diseases with which it has been associated. Fur-
thermore, most of the reported associations are with poly-
morphisms located in the TNF promoter region, and
cellular studies of gene regulation in vitro suggest that the
molecular basis of the disease association may be, at least in
some cases, a direct effect of the polymorphism on levels of
gene expression [3,12].
To pursue the causal origin of these TNF disease associa-
tions we must begin with a detailed understanding of the
allelic associations between different TNF SNPs. This is
particularly important considering that within a few
hundred base pairs, there are several potentially functional
polymorphisms which show apparently independent
disease associations with severe malaria [1-3]. Alterna-
tively, these TNF SNPs may be serving as neutral markers
of functional polymorphisms elsewhere in the central
MHC. In order to understand, first, how the TNF SNPs
relate to each other, and second, which SNPs are the best
markers of the TNF locus in general, we applied two new
analytical techniques to our haplotypic data. The first,
association efficiency analysis (AEA), precisely defines the
ability of one SNP to detect association at every other SNP
in a case-control scenario. The second technique, entropy
maximization method (EMM), selects those SNPs that
most effectively dissect the underlying haplotypic struc-
ture of a locus. The results of these analyses allow
us to prioritize SNPs for genotyping in future disease-
association studies.
Results 
Haplotyping the TNF locus 
Twelve SNPs spanning 4.3 kb (Figure 1) were genotyped in
212 Gambian and 84 Malawian adults with no missing data.
Allele frequencies for each SNP are listed in Table 1. The
Gambian genotypic data had 354/2,544 (14%) sites where
gametic phase was unknown, and the Malawian data had
188/1,008 (19%) sites where gametic phase was unknown.
Where available, genotypes from offspring of the adults were
used to phase these data (using the program PHAMILY),
which reduced the number to 127/2,544 (5%) phase-
unknown sites in the Gambian dataset and 75/1,008 (7%)
phase-unknown sites in the Malawian dataset. The data were
pooled and the program PHASE was then used to assign the
remaining phase-unknown sites. After inferring haplotypes,
only 6/2,544 (0.2%) phase assignments were less than 90%
certain in the Gambian dataset, and only 2/1,008 (0.2%)
phase assignments were less than 90% certain in the Malaw-
ian dataset. All other assignments (121/2,544 and 73/1,008)
were greater than 90% certain. These 424 Gambian haplo-
types and 168 Malawian haplotypes (Table 2) were the basis
of subsequent analyses reported.
Haplotype distributions in two populations 
In the Gambian sample, we observed 24 different haplo-
types, and the distribution was dominated by one major hap-
lotype (37.0%) and two others (16.7%, 16.5%) (Table 2,
Figure 2). Thirteen haplotypes of low frequency made up
another 28%, and 2% of alleles were singletons (haplotypes
observed only once in the sample). The gene diversity, or
probability that two haplotypes chosen at random from the
sample are different, was 0.80 (standard deviation (SD)
0.01). There is one nonrecombinant haplotype that is found
only in The Gambia (8). 
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Figure 1
Diagram of the TNF locus drawn to scale with SNPs indicated. Filled boxes represent exons and the open boxes represent the 3  untranslated region
(3  UTR). Positions are given in number of base pairs relative to the transcriptional start of TNF. The SNP at position -3025 is also referred to as an LT
NcoI restriction fragment length polymorphism in some references.
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LTα TNFThe Malawian sample included 21 different haplotypes, 13 of
which were shared with the Gambian population (Table 2,
Figure 2). The predominant haplotype in Malawi was not as
common, at 25.0%, and there were three other haplotypes
with frequencies greater than 10% (23.2%, 16.1% and 10.1%).
Haplotype 9, bearing the -1031C and -863A alleles, is much
more common in Malawi than in The Gambia, at 16.1%
versus 5.4%. Four percent of the Malawian alleles were
present as singletons. The gene diversity in Malawi was
slightly greater at 0.85 (SD 0.01).
Wright’s F statistic reveals differences between populations
by calculating the reduction in heterozygosity that is
expected after random mating between the two populations.
For the Gambian and Malawian populations the FST = 0.021.
Permutations of the data under a null hypothesis of no dif-
ferences between the populations gives a probability of
0.0001. An exact test of population differentiation finds the
observed haplotype distributions to be a poor fit of a model
of random mating between the Gambian and Malawian
samples, with a probability less than 10-5.
Recombination 
Results of the four-gamete test on pairs of SNPs in each pop-
ulation reveal that in The Gambia, 19/66 (29%) pairs of loci
have all four possible haplotypes present; while in Malawi,
15/55 (27%) pairs of SNPs have all four haplotypes present
(Figure 3). Some high-frequency (and presumably older)
SNPs show evidence of recombination in both populations
(TNF-3025, TNF-1031). In The Gambia, the TNF-308 SNP
shows evidence of recombination with six other SNPs. In
Malawi, the TNF-244 shows evidence of recombination
with many other SNPs. Interestingly, the TNF-863 SNP, of
relatively high frequency in Malawi, shows no evidence of
recombination with any other SNPs in the Malawian sample.
Recombinant haplotypes of frequency greater than 1% are
represented in Figure 2 with dotted lines. Although the
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Table 1
Allele frequencies of 12 SNPs at the TNF locus in two
populations
Polymorphism Gambia  (n = 424)  Malawi (n = 168)
TNF-3025 A/G  0.382  0.446
TNF-1073 T/C  0.002  0.030
TNF-1031 T/C  0.108  0.250
TNF-863 C/A  0.057  0.161
TNF-857 C/T  0.054  0.000
TNF-376 G/A  0.014  0.048
TNF-308 G/A  0.193  0.107
TNF-244 G/A  0.021  0.060
TNF-238 G/A  0.054  0.071
TNF+467 G/A  0.028  0.006
TNF+851 A/G  0.104  0.149
TNF+1304 A/G  0.085  0.131
Table 2
TNF haplotype frequencies in two populations
Gambia Malawi
Identifier Haplotype n Frequency n Frequency
1 ATTCCGGGGGAA 157 0.370 42 0.250
2  ..........GG  18 0.042 7 0.042 
3  ...........G  2 0.005 - -
4  ..........G.  - - 3 0.018 
5  .........A..  11 0.026 1 0.006
6  ........A...  2 0.005 - -
7  ......A.....  4 0.009 - -
8  ....T.......  22 0.052 - -
9  ..CA........ 23 0.054 27 0.161 
10  ..C.....A.GG 13 0.031 2 0.012
11 ..C......... 2 0.005 1 0.006
P ..C........G -- - -
12 ..C.......GG 1 0.002 - -
13 ..C....AA.GG - - 2 0.012
14 ..C...A..... 1 0.002 - -
15 ..C..A..A.G. 6 0.014 1 0.006
16 ..C..A..A.GG - - 4 0.024
17 ..C..A.AA.G. - - 1 0.006
18 ..C..A.AA.GG - - 2 0.012
19 G........... 70 0.165 39 0.232
20 G..........G - - 4 0.024
21 G.........G. 4 0.009 2 0.012
22 G.........GG 1 0.002 1 0.006
23 G......A.... 9 0.021 4 0.024
24 G...T....... 1 0.002 - -
25 G..A........ 1 0.002 - -
26 G.C......... - - 2 0.012
27 GC.......... 1 0.002 5 0.030
28 G.....A..... 71 0.167 17 0.101
29 G.....A...GG 1 0.002 - -
30 G.....A..A.. 1 0.002 - -
31 G.....A.A... 2 0.005 - -
32 G.....AA.... - - 1 0.006
424 168
SNPs are in genomic order from left to right as listed in Table 1. The
haplotype labeled “P” was found in two chimpanzees, a gorilla, and two
orang utans.branching structure of the TNF genealogy is similar in both
populations, there are unique recombination events that
have differentiated the two samples (haplotypes 17, 20 and
26). In Malawi, there appear to be more recombinant haplo-
types of greater than 1% frequency.
Linkage disequilibrium 
Consistent with the evidence for recombination, linkage dis-
equilibrium is variable across the TNF locus (Figure 4c,d)
and generally low. Values of pairwise linkage disequilibrium,
r2, are different between the two populations, though well
correlated (r = 0.83). In The Gambia, 80% of SNP pairs have
the minor alleles in the repulsion phase, while in Malawi,
65% of SNP pairs are in the repulsion phase. Most of the
SNP pairs in the repulsion phase have very low linkage
disequilibrium (r2 = 0). There are six pairs of SNPs that are
in the coupling phase in the Malawian sample, but are in the
repulsion phase in The Gambian sample, reversing the allelic
associations. Most of these occasions involve the TNF-244A
allele, which is found on only one haplotype in the Gambia
(in phase with the TNF-3025G allele), but on five different
haplotypes in Malawi.
Association efficiency analysis 
Using Equation (2) (see Materials and methods) we calculate
the apparent relative risk at one marker given a relative risk
of 10 at a second marker for all pairs of markers. As an
example, we assign a relative risk of 10 to the TNF-376A allele
(this is the relative risk of the A allele compared to the G
allele) and calculate the relative risks at all other SNPs in the
TNF gene using the haplotype frequencies from The Gambia
(Figure 5). Log10 of the relative risk is plotted on the y-axis, so
values above the x-axis correspond to disease risk while
values below the x-axis correspond to disease protection. We
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Figure 2
Minimum mutation networks of the TNF haplotypes. (a) The Gambian and (b) the Malawian population. Each circle represents a haplotype, and the size
of the circle is proportional to the haplotype frequency. Each connecting line corresponds to a mutational event, and the position of the resulting SNP is
indicated in base pairs from the transcriptional start of the gene. Broken lines indicate recombination. The numbers correspond to the haplotype
indentifiers listed in Table 2. Filled circles represent haplotypes that were not found in that population. The haplotype labelled ‘P’ was found in two
chimpanzees, a gorilla, and two orang utans. Haplotypes of frequency less than 1% are not shown.
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(a) (b)find that the relative risk varies greatly across the TNF gene
region. The three SNPs that are in maximum positive linkage
disequilibrium (D  = 1) with TNF-376A show relative risks of
2.2, 3.3, and 2.2 when TNF-376A gives a relative risk of 10.
The remaining eight SNPs in the TNF gene would have a
relative risk between 0.8 and 0.9 when the relative risk at
TNF-376A is 10 (Figure 4).
Data for all pairs of markers are given in Figure 4a,b. Hypo-
thetical disease alleles are given along the x-axis, and marker
alleles are given on the y-axis. Each cell indicates the appar-
ent relative risk (R) of a marker on the y-axis when the hypo-
thetical disease allele indicated on the x-axis has a relative
risk of 10. Using an arbitrary cutoff of 0.5 < R < 2.0 (indi-
cated by blue color), some markers perform poorly: for
example in The Gambia TNF-308 can only detect TNF-3025
(R = 2.9). Interestingly, if the TNF-308 SNP were a disease
allele, most of the other SNPs in TNF would show a moderate
protective effect. TNF-1031 is good at detecting associations
at seven other SNPs. In Malawi, the pattern of association
efficiency is different, and generally stronger. Most hypothet-
ical disease SNPs in Malawi would be detectable by other
SNPs in TNF, with the exception of TNF+476 and TNF-1073
which have very low frequency and little prospect of being
detected by other markers.
Association efficiency analysis compared to linkage
disequilibrium 
To illustrate the relationship between the association efficiency
parameter and measures of linkage disequilibrium, we plot the
log10 of relative risk for all pairs of SNPs (when one SNP is
assigned a relative risk of 10) against r2 (Figure 6a,b). Above
the x-axis, r2 appears to be correlated with the association effi-
ciency parameter (correlation coefficients of r = 0.77 in The
Gambia, and r = 0.91 in Malawi). Below the x-axis, where the
marker SNP gives an apparently protective effect, the correla-
tion is not as strong (r = -0.61 in The Gambia, r = -0.60 in
Malawi). In this situation where minor alleles are in the repul-
sion phase, the values for r2 remain low even when association
efficiency parameter shows a strong protective effect.
The association efficiency parameter is correlated with
D, the un-normalized linkage disequilibrium parameter
(Figure 6c,d). When the absolute value of D is great, the
association efficiency tends to be high; however, many SNP
pairs also have high association efficiency even when the
absolute value of D is low.
When we plot the association efficiency parameter against the
normalized disequilibrium parameter, D , we see a strong posi-
tive correlation: r = 0.89 in the Gambia and r = 0.91 in Malawi
(Figure 6e,f). Linkage disequilibrium is necessary to detect
association; however, it is not sufficient. Despite D  = 1.0, some
pairs of SNPs are poor markers of each other, showing rela-
tive risks between 0.5 and 2.0 when the linked hypothetical
disease allele gives a relative risk of 10. 
Entropy maximization method 
Entropy (E), a measure of haplotypic diversity, was calcu-
lated for the full 12-SNP haplotypes in each population
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Figure 3
Recombination in the TNF gene region. (a) Four-gamete test, The Gambia; (b) four-gamete test, Malawi. Red squares indicate pairs of SNPs in which all
four gametes were observed, which is evidence for recombination or recurrent mutation.
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(a) (b)(Equation (4) in Materials and methods). In the Gambian
sample, E = 2.95; in the Malawian sample, E = 3.23. To
determine if a subset of these 12 SNPs could account for
most of the haplotypic diversity in these samples, we calcu-
lated entropy for all possible subsets of SNPs, increasing
the number of SNPs in a subset from 1 to 12. In Figure 7 we
plot the subsets of markers with maximum entropy. We
begin with a single SNP, and with each additional SNP we
include, the entropy increases. The entropy plateaus when
the additional markers contribute little additional infor-
mation. To account for 95% of the haplotypic diversity of
TNF, one must genotype 8 of 12 SNPs in The Gambian
sample (in order of decreasing informativeness): -3025,
-308, 851, -1031, -857, 467, -244, -238; and type 7 SNPs
in the Malawian sample: -3025, -1031, 851, -308, 1304,
-244, -1073.
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Figure 4
Association efficiency and linkage disequilibrium parameters for 12 SNPs at the TNF locus. (a) AEA, Gambia; (b) AEA, Malawi; (c) linkage disequilibrium,
Gambia; (d) linkage disequilibrium, Malawi. The apparent relative risk at the marker allele indicated in the leftmost column is given when the hypothetical
disease allele indicated in the bottom row is assigned a relative risk of 10. In (a,b) color indicates the magnitude of the apparent relative risk: blue
indicates a relative risk of less than twofold, yellow between two- and fourfold, and red between fourfold and the maximum of 10-fold. In (c,d) red
indicates p < 0.05 by the chi-squared test, uncorrected for multiple tests.
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0.15 0.00 0.04 0.02 0.01 1.00 0.00 0.01 0.00 0.02 0.02
0.00 0.00 0.02 0.01 0.09 0.00 1.00 0.18 0.00 0.06 0.04
0.06 0.00 0.23 0.02 0.65 0.01 0.18 1.00 0.00 0.44 0.33
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00
0.08 0.01 0.05 0.03 0.29 0.02 0.06 0.44 0.00 1.00 0.53
0.03 0.01 0.03 0.03 0.17 0.02 0.04 0.33 0.00 0.53 1.00
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(c) (d)Discussion 
The TNF locus has been associated with susceptibility to a
wide range of infectious and inflammatory diseases. In
African populations, three TNF promoter SNPs have been
independently associated with severe malaria [1-3]. To
better understand these complex genetic associations with
malaria, we have defined the haplotypic structure of the TNF
gene region using 12 SNPs genotyped in 212 Gambian and
84 Malawian adults. Gametic phase was determined by
genotyping one offspring from each adult (when available),
reducing the number of phase-unknown sites by 65%. The
gametic phase of the remaining sites was determined by sta-
tistical inference. This integration of family- and population-
based methods of haplotype reconstruction resulted in phase
assignments of high certainty. This description of the
pattern of DNA sequence variation provides insight into the
genetic differentiation of these two African populations, the
evolution of the TNF gene itself, and the suitability of these
SNPs to serve as markers of disease association.
There are a number of interesting features that distinguish
these two populations at the haplotypic level. Eleven haplo-
types are unique to the Gambian sample, and eight are
unique to the Malawian sample. The haplotype bearing the
TNF-857T allele was not found in Malawi (this site is not
polymorphic in the Malawian sample), whereas it has a fre-
quency of 5.2% in The Gambia. When population differenti-
ation is assessed by haplotype instead of by individual SNP
frequencies, we observe a greater value for Wright’s fixation
index, FST = 0.021, compared to FST = 0.007 for individual
TNF SNPs [13]. Intragenic recombination seems to have had
an important role in diversifying the locus and in distin-
guishing the two populations, as evidenced by a number of
population-specific recombinant haplotypes (7, 17, 20 and
26). In spite of the significant differences in haplotype distri-
butions between the two African populations, it appears that
most of the haplotypes have evolved over a period of time
during which there was gene flow between the two sampled
populations. That is, the basic branching structure of the
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2003/4/4/R24                                                   Genome Biology 2003, Volume 4, Issue 4, Article R24 Ackerman et al. R24.7
Genome Biology 2003, 4:R24
Figure 5
AEA of the TNF-376 SNP. The TNF-376 SNP is assigned a hypothetical relative risk of 10, and the apparent relative risk at all other TNF SNPs is plotted
on a log10 scale (log10R). The positions of the other SNPs are indicated on the x-axis as base pairs from the start of transcription. Eight of the SNPs in the
TNF gene would give a relative risk between 0.8 and 0.9 when the TNF-376 SNP gives a hypothetical relative risk of 10.
-3025 -1073
-1031
-863
-857
-376
-308
-244
-238
467
851
1304
−4,000 −3,000 −2,000 −1,000 0 1,000 2,000
Base pairs
l
o
g
1
0
R
R=10
−1
−0.8
−0.6
−0.4
−0.2
0
0.2
0.4
0.6
0.8
1R24.8 Genome Biology 2003, Volume 4, Issue 4, Article R24 Ackerman et al. http://genomebiology.com/2003/4/4/R24
Genome Biology 2003, 4:R24
Figure 6
Plots of the AEA parameter versus linkage disequilibrium (LD) for all pairs of SNPs. The apparent relative risk for all marker SNPs (when paired with a
hypothetical disease SNP of relative risk = 10) is plotted on a log10 scale against measures of LD in (a,c,e) the Gambian and (b,d,f) the Malawian
populations. The AEA parameter is plotted against (a,b) r2, (c,d) D, and (e,f) D . The correlation coefficient (r) between the AEA parameter and the
measure of LD is indicated on each graph.
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0.4 0.6 0.8 1gene genealogy is the same in both populations, although
frequencies are different and there appear to be population
specific recombination events (Figure 2).
Our results have some similarities with a report of haplotype
structure across 13 megabases (Mb) in a sample of Yorubans
and African-Americans [14]. In a haplotype block defined by
12 SNPs, four haplotypes greater than 5% frequency were
found; we find five in the Gambia, and four in Malawi with
frequency greater than 5%. However, we find that a
minimum of 8 and 10 haplotypes make up 90% of the sample
in The Gambia and Malawi, respectively, while they report an
average minimum of 5 haplotypes. Furthermore, they report
values for D  that are constant across a haplotype block, while
we find variability in linkage disequilibrium, even over short
distances. Our data are more consistent with previous reports
of haplotypic structure where SNPs were ascertained by rese-
quencing in a large sample of chromosomes [15-17].
The increased frequency of haplotype 1 in the Gambian sample
has a profound impact on the allelic associations between SNPs
as evaluated by chi-square test or as defined by the pairwise
association efficiency parameter. The ‘star-shaped’ genealogy
of the Gambian TNF locus, dominated by one central haplotype
with many derived haplotypes defined by single mutational
events, produces negative disequilibria between most pairs of
SNPs (the rare alleles are found in the repulsion phase). The
chi-square test has low power to detect negative disequilibria
[18]; this may explain why in the case where p > 0.05, 41/42
SNP pairs have negative disequilibria. The ability of one
marker to detect another in a case-control scenario is also
greatly reduced when alleles are in the repulsion phase. For
example, in the Gambian sample, allele pairs in the repulsion
phase are much more likely to be inefficient markers (where
inefficient means the apparent relative risk at the marker SNP
is betwen 0.5 and 2.0 when the relative risk of the hypothetical
disease SNP is 10) than alleles in the coupling phase (p < 10-7).
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2003/4/4/R24                                                   Genome Biology 2003, Volume 4, Issue 4, Article R24 Ackerman et al. R24.9
Genome Biology 2003, 4:R24
Figure 7
Results of the entropy maximization method. Plots of the percentage of haplotypic diversity accounted for by a subset of SNPs as the size of the subset
goes from 1 SNP to 12 SNPs. The individual SNPs are labeled on the plot. The percentage is calculated as the entropy of the haplotype frequencies as
defined by the best n-SNP subset divided by the entropy of the haplotype frequencies as defined by all 12 SNPs, as n goes from 1 to 12. Note that the
order in which SNPs are included in an optimum subset differs between the two populations.
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(a) (b)Although linkage disequilibrium between a disease suscepti-
bility locus and a marker locus is required to detect an asso-
ciation with a complex disease, for a fixed sample size, it may
not be sufficient. Even in the extreme case when linkage dis-
equilibrium is at its theoretical maximum (D  = 100% and no
recombination has occurred between the two SNPs), the rel-
ative risk at the marker locus will be some fraction of the rel-
ative risk at the disease susceptibility locus, unless the two
alleles have the same frequency [19]. Using the relationship
defined in Equation 2 (see Materials and methods), we can
examine the haplotypic structure of a candidate locus and
assess the ability of one marker to detect a disease associa-
tion when a second marker contributes a given disease risk.
We calculate two values of apparent relative risk for each
pair of SNPs (assigning each SNP in turn a hypothetical risk
of 10) and plot them against D  (Figure 6). 
Pairs of SNPs where D  values are reversed between the pop-
ulations also show a reversal of the relative risk (that is, rela-
tive risks greater than 1 become less than 1). For example, if
the risk at SNP TNF+851 was 10, then the neighboring SNP,
TNF+467, would give a relative risk of 3.7 in Malawi, but in
the Gambian population, the effect would be protective with
a relative risk of 0.8. This suggests that even with a marker
in close physical proximity to a disease-susceptibility SNP,
results may differ greatly and even give apparently contra-
dictory results between two populations. This illustrates the
importance of identifying population-specific recombinant
chromosomes in the study populations. We identify six pairs
of SNPs that would reverse relative risks (that is, reverse the
sign of D) between the Gambian and Malawian populations.
Although the association efficiency parameter is correlated
with D  (r = 0.99 for combined data), it is interesting to con-
sider the situation where D  = 1.00 between the marker and
hypothetical disease SNPs. In this situation, the apparent
relative risk at a marker SNP may be considerably lower
than at the disease SNP (Figure 6). This is especially evident
in the Malawian population. These observations suggest that
linkage-disequilibrium measures, as summarized by D , may
not accurately reflect the ability of a marker to detect a
disease association. 
It is troubling to observe that even within a relatively small
gene like TNF (4.3 kb in this study) the SNP markers are poorly
correlated: if a true disease-susceptibility allele existed in the
TNF gene, many of the other SNPs would be inefficient
markers of that disease allele. Our calculations reveal that even
if a hypothetical disease allele gave a 10-fold increased risk, out
of the 132 possible pairs of SNPs, in 92 of them (70%), the
marker would show a relative risk of less than twofold. Only a
small minority of SNP pairs are efficient enough to detect a
strong disease-modifying SNP in the TNF gene region.
Although it appears that individual SNPs in TNF are poor
markers of each other, it is important to ask which SNPs
serve as good markers of the TNF haplotypes. Depending on
the haplotypic structure of a gene region, one may be able to
choose a small subset of SNPs that capture most of the haplo-
typic diversity, thus reducing the cost of genotyping signifi-
cantly with only modest reductions in information [20-22].
Two methods have been reported that select the best subset
of SNPs [20,23]. In this paper we introduce a third, the
entropy maximization method (EMM), which chooses the
subset of SNPs that explains the largest proportion of the
underlying haplotypic diversity as measured by entropy.
The single SNP with maximum entropy is the SNP with fre-
quency closest to 0.50, in this case TNF-3025. In both popu-
lations, this SNP represents about one-third of the
haplotypic diversity. With the addition of a second SNP to
form a two-SNP haplotype, one-half of the haplotypic diver-
sity is accounted for. In The Gambia, it is most informative
to include the TNF-308 SNP as a second marker, whereas in
Malawi, the TNF-1031 SNP contributes the most as a second
marker. It is not surprising that the first few SNPs selected
by the EMM are those that have frequencies closest to 0.50;
however, the addition of a common SNP that is well corre-
lated with a SNP already in the subset will contribute little
additional information.
For example, in the Gambian sample, the four most common
SNPs are selected first by the EMM (TNF-3025 (38%), TNF-
308 (19%), TNF+851 (10%), TNF-1031 (11%)). The next most
common SNPs are the TNF+1304 (9%) and the TNF-863
(6%); however, the EMM does not choose these SNPs next
because the TNF+1304 tends to occur in phase with the
TNF+851, and the TNF-863 tends to occur in phase with the
TNF-1031, both of which are already in the subset of four
SNPs. So the next two choices that maximize entropy are the
TNF-857 and TNF+467 SNPs, which, although less
common, represent haplotypes previously unaccounted for
(5 and 8). These six-SNP haplotypes now represent about
90% of the haplotypic diversity. Two more SNPs must be
added (for a total of eight) before 95% of the 12-SNP haplo-
typic diversity is accounted for.
In Malawi, the general features of marker selection are the
same, though the optimal SNPs are different. Three of the
four most common SNPs are selected first by the EMM
(TNF-3025 (45%), TNF-1031 (25%), TNF+851 (15%)), fol-
lowed by the TNF-308 (11%) and TNF+1304 (13%) SNPs.
Interestingly, population-specific recombinant haplotypes
make the TNF+1304 SNP more informative in Malawi; it is
required to resolve haplotypes 2 and 4 and haplotypes 21
and 22, which together make up almost 10% of all the haplo-
types. In Malawi seven SNPs must be included to represent
95% of the 12-SNP haplotypic diversity.
EMM is especially useful when combined with AEA. The
latter can be used to determine how well the recommended
haplotype-tagging SNPs detect association at a particular
R24.10 Genome Biology 2003, Volume 4, Issue 4, Article R24 Ackerman et al. http://genomebiology.com/2003/4/4/R24
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adjust the power of an association study accordingly.
Analysis of the TNF locus in two African populations reveals
a haplotypically diverse locus where markers are only weakly
associated with each other. Although initial detection of a
disease association in TNF may be difficult, weak allelic
associations within the TNF gene region will make it possi-
ble to distinguish a disease-modifying SNP from its neigh-
bors. Future studies may determine that this is a general
feature of African genomes.
Materials and methods 
Subjects 
Healthy unrelated adults were recruited in Banjul, The
Gambia and in Blantyre, Malawi. All were parents of chil-
dren who presented to hospital with severe malaria. All sub-
jects gave informed consent and the study was approved by
the Gambia Government/Medical Research Council Joint
Ethical Committee and the College of Medicine Research
Committee of the University of Malawi.
After excluding erroneous pedigrees, the 187 parent-child
pairs plus 45 other adults comprised the Gambian sample (a
total of 212 adults), and 70 parent-child pairs plus 14 other
adults (a total of 84 adults) comprised the Malawian sample.
We also studied DNA from two chimpanzees, one gorilla and
two orang utans.
SNP identification and genotyping 
In a previous study, we described the nucleotide diversity of
the TNF locus in 36 healthy, unrelated Gambian adults [13].
There we identified 11 SNPs by forward and reverse sequenc-
ing of the entire TNF gene from -1,389 bp relative to the
start of transcription to +3,004 bp on 72 chromosomes.
Here we have genotyped the 11 SNPs identified in TNF, plus
one SNP in the neighboring gene, LT, in a sample of 212
Gambian and 84 Malawian adults. The amplification refrac-
tory mutation system PCR (ARMS-PCR) was used to geno-
type the polymorphisms identified by sequencing. Methods
are as previously described [13]. The accuracy of the ARMS-
PCR method was tested on sequenced individuals before
extending it to DNA samples of unknown genotype.
Haplotype construction 
For most of these adults, genotypes were available from their
children, raising the question of how to construct haplotypes
most efficiently from a dataset where pedigree information is
available for some but not all individuals. We developed a
program PHAMILY, which uses information from two-
generation pedigrees to construct parental haplotypes at all
unambiguous sites. These partial haplotypes of unambiguous
sites serve as input for PHASE [24,25], which uses the
Stephens-Donnelly method of haplotype construction to assign
the remaining phase-unknown sites among the unrelated
parents. The two study populations were pooled before
haplotype construction; after haplotype construction, indi-
viduals were assigned to their original populations on the
basis of their sample identifiers.
Population genetic analyses 
Estimating gene diversity
An estimate of gene diversity (H), the probability that two
randomly chosen haplotypes are different in a sample, was
calculated using Equation 8.5 from Nei [26], 
H = n —— n-11-
k
i=1
pi
2
where n is the number of gene copies in the sample, k is the
number of different haplotypes, and pi is the frequency of
the  ith haplotype. The sampling variance of this estimate
was calculated according to Nei and Roychoudhury [27]. The
computer software Arlequin was used to perform these cal-
culations [28,29].
Construction of haplotype networks 
Network2.0c was used to construct median-joining networks
of the haplotypic data [30]. Because of the occurrence of
many low-frequency recombinant haplotypes in the dataset,
only haplotypes observed twice or more were represented in
the network. Output from Network2.0c was critically evalu-
ated and some modifications made to best fit a model of
minimum mutation.
Four-gamete test 
All pairs of biallelic SNPs were cross-tabulated to identify
the number of unique two-locus haplotypes present. An
observation of four different haplotypes from a pair of bial-
lelic loci was considered evidence for recombination or
recurrent mutation.
Population differentiation and pairwise FST
Pairwise FST was calculated as the genetic variance among
populations divided by the genetic variance of the total pop-
ulation using haplotypic data [31]. An exact test of popula-
tion differentiation was applied to the haplotypic data [32].
The computer software Arlequin was used to perform these
calculations [28,29].
Linkage disequilibrium calculations 
Pairwise linkage disequilibria were calculated using the r2
statistic. Terms for allele and two-locus haplotype frequen-
cies are given in Table 3. r2 was calculated using
D r2 = 
————————
2
——————  p1p2q1q2
where D = f11 f22 - f12 f21. Normalized linkage disequilibrium
parameters D  were calculated using the method of Lewontin
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Genome Biology 2003, 4:R24[33] in Hartl and Clark [34]. Statistical significance of the
standardized linkage disequilibrium parameter was calcu-
lated using the formula 
D 2 = N
————————
2
——————  p1p2q1q2
with one degree of freedom [34], where N is the number of
chromosomes.
Association efficiency analysis (AEA) 
To assess the ability of one marker to detect a given disease
association at a second marker, we derived a measure we call
association efficiency, which is the relative risk at one SNP
by virtue of its association with a second SNP. Consider a
disease-modifying SNP A that is in linkage disequilibrium
with a neighboring nonfunctional SNP B. We define RA as
the relative risk associated with allele A2 compared to allele
A1. Under a multiplicative mode of inheritance, the frequen-
cies of the different haplotypes (A1B1, A1B2, A2B1, A2B2)
found in diseased individuals is expected to be f11, f12, RAf21,
and RAf22 (see Table 3). Given the risk associated with A2
and the frequency of each haplotype, we can derive the fre-
quency of allele B2 among diseased individuals (q2 ). 
f12 + RA f22
q2  = ————————————————— (1)
f11 + f12 + RA f21 + RA f22
The frequency of allele B2 in the general population is defined
as q2. Thus, in a case-control study where diseased individu-
als are compared to individuals drawn from the general pop-
ulation, we would obtain an odds ratio for allele B2 of 
(1 - q2)(RA f22+ f12)
RB = ————————————————— (2)
q2 (RA f21 + f11)
This odds ratio provides an approximation of the relative
risk that is associated with the non-functional allele B2 by
virtue of its association with the disease allele A2.
When locus B is considered to be the disease-modifying
locus, with RB as the relative risk associated with allele B2
compared to B1, it can be shown that the relative risk at
locus A is 
(1 - p2)(RBf22+ f21)
RA = ————————————————— (3)
p2 (RBf12 + f11)
In this paper, we consider the possibility that the rarer allele
gives a true relative risk of 10 for a given disease, and calcu-
late the apparent relative risk at all other loci. We do this for
all pairs of loci. Because this property does not commute
(that is, the apparent relative risk at locus B given a true rel-
ative risk of 10 at locus A is not necessarily equal to the
apparent relative risk at locus A given a true relative risk of
10 at locus B) we calculate two values for each pair of SNPs.
Entropy maximization method (EMM) 
A measure of haplotypic diversity, entropy (E), was calcu-
lated using 
E = -
k
i=1
pi log pi (4)
where pi is the frequency of the ith haplotype, and k is the
number of unique haplotypes in the sample. Entropy is
maximized when all haplotypes have the same frequency.
We developed an algorithim that chooses SNPs, first indi-
vidually, then in multi-SNP haplotypes, that maximize
entropy [35]. Thus we can define a subset of SNPs that rep-
resent the greatest proportion of the full 12-SNP haplotypic
diversity. This method provides for the selection of optimal
haplotype-tagging SNPs even in the absence of a clear
haplotypic block structure.
Additional data files
The algorithm that chooses SNPs, first individually, then in
multi-SNP haplotypes that maximize entropy, is available
with the online version of this article and from [35].
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